DOCSLIB.ORG

Facts & Figures

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

excellence in life sciences Reykjavik Helsinki Oslo EMBO facts & figures & EMBO facts Tallinn Stockholm Copenhagen Vilnius Dublin Amsterdam Berlin Warsaw London Brussels Prague Bratislava Paris Luxembourg Budapest Bern Vienna Ljubljana Zagreb Rome Madrid Ankara Lisbon Athens Valletta Jerusalem New Delhi Singapore EMBO facts & figures HIGHLIGHTS CONTACT EMBO & EMBC Membership new members from countries in Europe and eight EMBO Young Investigators Associate Members from China, Japan, Lithuania, Singapore and EMBO Installation Grants the United States were elected. EMBO Women in Science Fellowships Long-Term Fellowships opened for applications all year round EMBO Courses & Workshops and new eligibility criteria for Short-Term Fellowships were EMBO Keynote Lectures R Gerlind Wallon EMBO Scientific Publications I introduced. C H Programme Manager Bernd Pulverer A Long-Term, Short-Term and Advanced Fellowships R Maria Leptin Deputy Director Head D were awarded. EMBO Director + + B BE E N 6 N TON 201 Young Investigators and Lithuania joined the Installation Grants scheme. LE Installation Grants H N Young Investigators and Installation Grantees became part ER 2016 of the EMBO community. Science Policy EMBO co-organised a workshop on science advising in Europe. Eilish Craddock Personal Assistant to Science Policy Programme Manager Michele Gar nkel was EMBO Fellowships EMBO Scientific Publications the EMBO Director invited to represent EMBO on the European Commission’s Open David del Álamo Thomas Lemberger + 7th Science Policy Platform. Programme Manager Deputy Head The programme continued its work on research integrity, + + including presentations at European institutes and improve- advancing the life sciences ments to the online training course. 2016 Courses & Workshops More than , participants attended scienti c events. Mannheim EMBO Laboratory Management Courses were held in GERMANY Heidelberg and at six research institutes worldwide. 10 – 13 September Administration & Finance EMBO Global Activities EMBO Communications The th EMBO Meeting in Mannheim concluded the meeting Bernhard Huber Luis Valente Tilmann Kießling series. Head Head Head + + + Global Activities Malta and Lithuania become EMBC Member States. EMBO partners with the Wellcome Trust/DBT India Alliance to deliver three life science meetings per year in India. Awards The EMBO Gold Medal was awarded to Richard Benton and Ben Lehner. EMBC EMBO Membership & EMBO Council & Committees EMBO Science Policy Elections Fiona Watt received the FEBS | EMBO Women in Science Award. Gitta Bourke Michele Garfinkel Volker Wiersdorff EMBO Press EMBO Press extended its scooping protection policy to preprints. Administrator Programme Manager Head SourceData The SmartFigures lab application of SourceData was developed + + + in collaboration with publishing house Wiley and launched at The EMBO Meeting. Complete list of EMBO staff in Heidelberg on pages . EMBO facts & figures 2016 EMBO promotes excellence in life sciences in Europe and beyond by recognizing and fostering talented scientists. Since 1964, leading scientists are elected annually to become EMBO Members based on proven excellence in research. Members number more than 1700 today. 85 scientists from the EMBO membership have received the Nobel Prize. EMBO funding, training and networking activities attract thousands of scientists every year, promoting collaboration in all areas of life science research. Four peer-reviewed journals span a broad spectrum of the life sciences and reflect how research is shaping the world. The European Molecular Biology Conference (EMBC), founded in 1969, is the intergovernmental funding body for EMBO comprising 29 member states including most of the European Union and some of the neighbouring countries. Both EMBO and EMBC are driven by a common commitment to research at the European level. Their joint activities are characterized by quality and encouragement of co-operation within the scientific community. EMBO facts & figures 2016 reports on the implementation of the EMBC General Programme and other EMBO activities. table of contents EMBO Fellowships 24 – 73 Preface 4 – 5 EMBO Long-Term Fellowships 24 – 41 EMBO actions in 2016 6 – 7 Statistics 24 – 25 EMBC actions in 2016 8 – 9 Awards 2016 26 – 38 Geographical distribution 2016 40 – 41 EMBO Advanced Fellowships 42 facts & figures 2016 EMBO Short-Term Fellowships 43 – 73 Statistics 43 EMBC Member States 12 – 13 Awards 2016 44 – 71 Delegates and Advisers 12 Geographical distribution 2016 72 – 73 Financial contributions 13 EMBO Young Investigators 74 – 81 EMBO Council & Committees 14 – 15 Young Investigators 2016 74 – 75 EMBO Council 2016 14 Young Investigators 2000 – 2016 76 – 77 EMBO Committees 2016 15 Applications and awards 2006 – 2016 78 EMBO Membership 16 – 19 Lectures 2016 79 – 81 EMBO Members 2016 16 – 18 EMBO Installation Grants 82 EMBO Associate Members 2016 19 Installation Grantees 2016 82 EMBO Scientific Publications 20 – 23 EMBO Courses & Workshops 83 – 88 Advisory Editorial Boards & Senior Editors of Practical Courses 2016 83 – 84 The EMBO Journal 20 Workshops 2016 84 – 85 EMBO reports 21 Conferences 2016 85 – 86 Molecular Systems Biology 22 Symposia 2016 87 EMBO Molecular Medicine 23 EMBO | FEBS Lecture Courses 2016 87 Global Exchange Lecture Courses 2016 87 Laboratory Management Courses 2016 88 EMBO Women in Science 89 – 93 Participation of women in EMBO activities: Statistics 89 – 93 EMBO Gold Medal 94 Gold Medalists 1986 – 2016 94 EMBO Keynote Lectures 95 – 97 Keynote Lectures 2016 95 – 97 EMBO Staff in Heidelberg 98 – 99 EMBO facts & figures 2016 | www.embo.org 3 Preface I am pleased to present this collection of figures highlight- ing the variety, progress and impact of EMBO’s activities dur- ing 2016. Through its programmes and activities, EMBO con- tinued to support and connect life scientists across Europe and beyond. It was a particular pleasure to have three new countries join the EMBC. With Malta and Lithuania becoming EMBC Members States and India joining as Associate Member State, more researchers will be able to benefit from the support EMBO offers talented researchers at all stages of their careers. Demonstrating that excellence remains at the heart of the Maria Leptin organisation, EMBO welcomed 58 of the best life scientists EMBO Director from 18 countries to the EMBO Membership, and 25 of the most promising young group leaders were selected as EMBO Young Investigators. Celebrating individual achievements in the life sciences, we awarded the EMBO Gold Medal to Rich- ard Benton and Ben Lehner and the FEBS | EMBO Women in Science Award to Fiona Watt. EMBO’s funding programmes have continued to support talented researchers at all career stages. Looking ahead we must ensure that the EMBO Programmes stay at the forefront of supporting young scientists in building successful, inter- nationally mobile careers. With this in mind, we made the application process for Long-Term Fellowships more flexible by removing the application deadline, and introduced new eli- gibility criteria for the Short-Term Fellowships to make them available to more researchers in EMBC Member States. EMBO Courses & Workshops reach thousands of life scien- tists from across the globe every year at events where they can exchange information, receive training and connect with each other – and 2016 was no exception. The programme supported 92 events attended by more than 11,000 people. Additionally, members of the EMBO community were able to interact with 4 Preface | Maria Leptin EMBO facts & figures 2016 | www.embo.org peers outside their immediate research areas at the annual EMBO Press has continued to shape best practice in sci- EMBO Members’ Meeting and two Fellows’ Meetings in Ger- entific publishing. Aspects of the EMBO Press ‘Transparent many and the USA. Process’ have been adopted by other journals. In addition, all 30 EMBO Laboratory Management Courses offered 478 EMBO Press publications introduced an extended scooping young researchers the opportunity to develop their manage- protection: manuscripts posted as preprints before submission ment and leadership skills, and we extended the portfolio to will not be rejected on the basis of similar findings published include courses on negotiation and self-leadership. Another by other researchers during the submission, peer-review or development saw the conclusion of The EMBO Meeting series revision process. with the seventh meeting in Mannheim. Acting on feedback The numbers in this publication speak for themselves: from the community, EMBO Council agreed to discontinue EMBO’s activities continue to positively influence the life sci- this large, multidisciplinary meeting – a decision that will en- ences in Europe and the rest of the world. The financial sup- able us to use our resources to explore new opportunities for port from the EMBC Member States, the guidance from EMBO bringing top science to the widest audiences. Examples of this Council, the dedication of the EMBO Members, and the en- are the joint ASCB | EMBO meeting in 2017 and the partner- thusiastic work of the EMBO office staff are vital for EMBO’s ship EMBO formed with the Wellcome Trust/DBT India Alli- ongoing success. I would like to thank everyone involved with ance to organize additional meetings in India. the organisation, and I look forward to working together to In addition to supporting researchers and stimulating the continue to deliver and develop EMBO’s activities. exchange of information,
Recommended publications
  • Research Development Innovation 2013/2014 Report

    Research Development Innovation 2013/2014 Report

    Centro Nacional de Biotecnología Campus de Cantoblanco RESEARCH Darwin 3, Madrid 28049, Spain Tel.: [+ 34] 91 585 4500 / Fax: [+ 34] 91 585 4506 DEVELOPMENT www.cnb.csic.es INNOVATION 2013/2014 REPORT INDEX Welcome to the CNB ................................................................................................................................................. 9 Carmen Castresana 1 / Plant Molecular Genetics 13 Genetic and molecular basis of naturally-occurring variation in plant development .............................................. 14 Carlos Alonso-Blanco Plant immunity strategies against microbial pathogen infection .............................................................................. 15 Carmen Castresana Genetic control of shoot branching patterns in plants ............................................................................................. 16 Pilar Cubas Plant-pathogen interaction in viral infections ........................................................................................................... 17 Juan Antonio García / Carmen Simón Genes involved in root architecture and in arsenic phytoremediation .................................................................... 18 Antonio Leyva Tejada Regulation of gene activity in plants: the phosphate starvation rescue system ...................................................... 19 Javier Paz-Ares Light signalling and day length control of potato tuber formation ........................................................................... 20 Salomé
  • Identification and Dynamics of the Human ZDHHC16-ZDHHC6 Palmitoylation Cascade

    Identification and Dynamics of the Human ZDHHC16-ZDHHC6 Palmitoylation Cascade

    RESEARCH ARTICLE Identification and dynamics of the human ZDHHC16-ZDHHC6 palmitoylation cascade Laurence Abrami1†, Tiziano Dallavilla1,2†, Patrick A Sandoz1, Mustafa Demir1, Be´ atrice Kunz1, Georgios Savoglidis2, Vassily Hatzimanikatis2*, F Gisou van der Goot1* 1Global Health Institute, Faculty of Life Sciences, Ecole Polytechnique Fe´de´rale de Lausanne, Lausanne, Switzerland; 2Laboratory of Computational Systems Biotechnology, Faculty of Basic Sciences, Ecole Polytechnique Fe´de´rale de Lausanne, Lausanne, Switzerland Abstract S-Palmitoylation is the only reversible post-translational lipid modification. Knowledge about the DHHC palmitoyltransferase family is still limited. Here we show that human ZDHHC6, which modifies key proteins of the endoplasmic reticulum, is controlled by an upstream palmitoyltransferase, ZDHHC16, revealing the first palmitoylation cascade. The combination of site specific mutagenesis of the three ZDHHC6 palmitoylation sites, experimental determination of kinetic parameters and data-driven mathematical modelling allowed us to obtain detailed information on the eight differentially palmitoylated ZDHHC6 species. We found that species rapidly interconvert through the action of ZDHHC16 and the Acyl Protein Thioesterase APT2, that each species varies in terms of turnover rate and activity, altogether allowing the cell to robustly *For correspondence: tune its ZDHHC6 activity. [email protected] DOI: https://doi.org/10.7554/eLife.27826.001 (VH); [email protected] (FGG) †These authors contributed equally to this work Introduction Cells constantly interact with and respond to their environment. This requires tight control of protein Competing interests: The function in time and in space, which largely occurs through reversible post-translational modifica- authors declare that no tions of proteins, such as phosphorylation, ubiquitination and S-palmitoylation.
  • Female Fellows of the Royal Society

    Female Fellows of the Royal Society

    Female Fellows of the Royal Society Professor Jan Anderson FRS [1996] Professor Ruth Lynden-Bell FRS [2006] Professor Judith Armitage FRS [2013] Dr Mary Lyon FRS [1973] Professor Frances Ashcroft FMedSci FRS [1999] Professor Georgina Mace CBE FRS [2002] Professor Gillian Bates FMedSci FRS [2007] Professor Trudy Mackay FRS [2006] Professor Jean Beggs CBE FRS [1998] Professor Enid MacRobbie FRS [1991] Dame Jocelyn Bell Burnell DBE FRS [2003] Dr Philippa Marrack FMedSci FRS [1997] Dame Valerie Beral DBE FMedSci FRS [2006] Professor Dusa McDuff FRS [1994] Dr Mariann Bienz FMedSci FRS [2003] Professor Angela McLean FRS [2009] Professor Elizabeth Blackburn AC FRS [1992] Professor Anne Mills FMedSci FRS [2013] Professor Andrea Brand FMedSci FRS [2010] Professor Brenda Milner CC FRS [1979] Professor Eleanor Burbidge FRS [1964] Dr Anne O'Garra FMedSci FRS [2008] Professor Eleanor Campbell FRS [2010] Dame Bridget Ogilvie AC DBE FMedSci FRS [2003] Professor Doreen Cantrell FMedSci FRS [2011] Baroness Onora O'Neill * CBE FBA FMedSci FRS [2007] Professor Lorna Casselton CBE FRS [1999] Dame Linda Partridge DBE FMedSci FRS [1996] Professor Deborah Charlesworth FRS [2005] Dr Barbara Pearse FRS [1988] Professor Jennifer Clack FRS [2009] Professor Fiona Powrie FRS [2011] Professor Nicola Clayton FRS [2010] Professor Susan Rees FRS [2002] Professor Suzanne Cory AC FRS [1992] Professor Daniela Rhodes FRS [2007] Dame Kay Davies DBE FMedSci FRS [2003] Professor Elizabeth Robertson FRS [2003] Professor Caroline Dean OBE FRS [2004] Dame Carol Robinson DBE FMedSci
  • The Ubiquitin Proteasome System and Its Involvement in Cell Death Pathways

    The Ubiquitin Proteasome System and Its Involvement in Cell Death Pathways

    Cell Death and Differentiation (2010) 17, 1–3 & 2010 Macmillan Publishers Limited All rights reserved 1350-9047/10 $32.00 www.nature.com/cdd Editorial The ubiquitin proteasome system and its involvement in cell death pathways F Bernassola1, A Ciechanover2 and G Melino1,3 Cell Death and Differentiation (2010) 17, 1–3; doi:10.1038/cdd.2009.189 Following the awarding of the 2004 Nobel Prize in Chemistry Inactivation of the proteasome following caspase-mediated to Aaron Ciechanover, Avram Hershko, and Irwin A Rose cleavage may disable the proteasome, interfering with its for the discovery of ubiquitin (Ub)-mediated degradation, role in the regulation of key cellular processes and thereby Cell Death and Differentiation has drawn the attention of facilitating induction of apoptosis. The noted recent develop- its readers to the Ub Proteasome System (UPS) and its ments show how understanding of these functions is just involvement in regulating cell death pathways.1–4 The current starting to emerge. For example, why does dIAP1 associate set of reviews is an update on this theme.5–16 with multiple E2s via its RING finger? Does dIAP1 also interact From previous review articles published in Cell Death and with the E3 – the F-box protein Morgue, which is a part of an Differentiation, it was apparent that the UPS has a major SCF E3 complex? Why does dIAP1, which is an E3, have to mechanistic role in regulating cell death via modification and interact with other ligases such as the N-end rule UBR1 and degradation of key regulatory proteins involved in
  • The Role of Model Organisms in the History of Mitosis Research

    The Role of Model Organisms in the History of Mitosis Research

    Downloaded from http://cshperspectives.cshlp.org/ on September 30, 2021 - Published by Cold Spring Harbor Laboratory Press The Role of Model Organisms in the History of Mitosis Research Mitsuhiro Yanagida Okinawa Institute of Science and Technology Graduate University, Okinawa 904-0495, Japan Correspondence: [email protected] Mitosis is a cell-cycle stage during which condensed chromosomes migrate to the middle of the cell and segregate into two daughter nuclei before cytokinesis (cell division) with the aid of a dynamic mitotic spindle. The history of mitosis research is quite long, commencing well before the discovery of DNA as the repository of genetic information. However, great and rapid progress has been made since the introduction of recombinant DNA technology and discovery of universal cell-cycle control. A large number of conserved eukaryotic genes required for the progression from early to late mitotic stages have been discovered, confirm- ing that DNA replication and mitosis are the two main events in the cell-division cycle. In this article, a historical overview of mitosis is given, emphasizing the importance of diverse model organisms that have been used to solve fundamental questions about mitosis. Onko Chisin—An attempt to discover new truths by checkpoint [SAC]), then metaphase (in which studying the past through scrutiny of the old. the chromosomes are aligned in the middle of cell), anaphase A (in which identical sister chro- matids comprising individual chromosomes LARGE SALAMANDER CHROMOSOMES separate and move toward opposite poles of ENABLED THE FIRST DESCRIPTION the cell), anaphase B (in which the spindle elon- OF MITOSIS gates as the chromosomes approach the poles), itosis means “thread” in Greek.
  • Gurdon Institute 20122011 PROSPECTUS / ANNUAL REPORT 20112010

    Gurdon Institute 20122011 PROSPECTUS / ANNUAL REPORT 20112010

    The Wellcome Trust/Cancer Research UK Gurdon Institute 20122011 PROSPECTUS / ANNUAL REPORT 20112010 Gurdon I N S T I T U T E PROSPECTUS 2012 ANNUAL REPORT 2011 http://www.gurdon.cam.ac.uk CONTENTS THE INSTITUTE IN 2011 INTRODUCTION........................................................................................................................................3 HISTORICAL BACKGROUND..........................................................................................................4 CENTRAL SUPPORT SERVICES....................................................................................................5 FUNDING.........................................................................................................................................................5 RETREAT............................................................................................................................................................5 RESEARCH GROUPS.........................................................................................................6 MEMBERS OF THE INSTITUTE................................................................................44 CATEGORIES OF APPOINTMENT..............................................................................44 POSTGRADUATE OPPORTUNITIES..........................................................................44 SENIOR GROUP LEADERS.............................................................................................44 GROUP LEADERS.......................................................................................................................48
  • 2016 Joint Meeting Program

    2016 Joint Meeting Program

    April 15 – 17, 2016 Fairmont Chicago Millennium Park • Chicago, Illinois The AAP/ASCI/APSA conference is jointly provided by Boston University School of Medicine and AAP/ASCI/APSA. Meeting Program and Abstracts www.jointmeeting.org www.jointmeeting.org Special Events at the 2016 AAP/ASCI/APSA Joint Meeting Friday, April 15 Saturday, April 16 ASCI President’s Reception ASCI Food and Science Evening 6:15 – 7:15 p.m. 6:30 – 9:00 p.m. Gold Room The Mid-America Club, Aon Center ASCI Dinner & New Member AAP Member Banquet Induction Ceremony (Ticketed guests only) (Ticketed guests only) 7:00 – 10:00 p.m. 7:30 – 9:45 p.m. Imperial Ballroom, Level B2 Rouge, Lobby Level How to Solve a Scientific Puzzle: Speaker: Clara D. Bloomfield, MD Clues from Stockholm and Broadway The Ohio State University Comprehensive Cancer Center Speaker: Joe Goldstein, MD APSA Welcome Reception & University of Texas Southwestern Medical Center at Dallas Presidential Address APSA Dinner (Ticketed guests only) 9:00 p.m. – Midnight Signature Room, 360 Chicago, 7:30 – 9:00 p.m. John Hancock Center (off-site) Rouge, Lobby Level Speaker: Daniel DelloStritto, APSA President Finding One’s Scientific Niche: Musings from a Clinical Neuroscientist Speaker: Helen Mayberg, MD, Emory University Dessert Reception (open to all attendees) 10:00 p.m. – Midnight Imperial Foyer, Level B2 Sunday, April 17 APSA Future of Medicine and www.jointmeeting.org Residency Luncheon Noon – 2:00 p.m. Rouge, Lobby Level 2 www.jointmeeting.org Program Contents General Program Information 4 Continuing Medical Education Information 5 Faculty and Speaker Disclosures 7 Scientific Program Schedule 9 Speaker Biographies 16 Call for Nominations: 2017 Harrington Prize for Innovation in Medicine 26 AAP/ASCI/APSA Joint Meeting Faculty 27 Award Recipients 29 Call for Nominations: 2017 Harrington Scholar-Innovator Award 31 Call for Nominations: George M.
  • Roger D. Kornberg Stanford University, School of Medicin, Fairchild D 123, Stanford, CA 94305-5126, USA

    Roger D. Kornberg Stanford University, School of Medicin, Fairchild D 123, Stanford, CA 94305-5126, USA

    THE MOLECULAR BASIS OF EUKARYOTIC TRANSCRIPTION Nobel Lecture, December 8, 2006 by Roger D. Kornberg Stanford University, School of Medicin, Fairchild D 123, Stanford, CA 94305-5126, USA. I am deeply grateful for the honor bestowed on me by the Nobel Committee for Chemistry and the Royal Swedish Academy of Sciences. It is an honor I share with my collaborators. It is also recognition of the many who have con- tributed over the past quarter century to the study of transcription. THE NUCLEOSOME My own involvement in studies of transcription began with the dis- covery of the nucleosome, the basic unit of DNA coiling in eukaryote chromosomes [1]. X-ray studies and protein chemistry led me to propose the wrapping of DNA around a set of eight histone molecules in the nucleosome (Fig. 1). Some years later, Yahli Lorch and I found this wrapping of DNA prevents the ini- tiation of transcription in vitro [2]. Michael Grunstein and colleagues showed nucleosomes interfere with transcription in vivo [3]. The nuc- leosome serves as a general gene repressor. It assures the inactivity of all the many thousands of genes in eukaryotic cells except those Figure 1. The nucleosome, fundamental whose transcription is brought particle of the eukaryote chromosome. about by specific positive regulatory Schematic shows the coiling of DNA around mechanisms. What are these posi- a set of eight histones in the nucleosome, tive regulatory mechanisms? How is the further coiling in condensed (transcrip- tionally inactive) chromatin, and uncoiling repression by the nucleosome over- for interaction with the RNA polymerase II come for transcription? Our recent (pol II) transcription machinery.
  • EMBC Annual Report 2007

    EMBC Annual Report 2007

    EMBO | EMBC annual report 2007 EUROPEAN MOLECULAR BIOLOGY ORGANIZATION | EUROPEAN MOLECULAR BIOLOGY CONFERENCE EMBO | EMBC table of contents introduction preface by Hermann Bujard, EMBO 4 preface by Tim Hunt and Christiane Nüsslein-Volhard, EMBO Council 6 preface by Marja Makarow and Isabella Beretta, EMBC 7 past & present timeline 10 brief history 11 EMBO | EMBC | EMBL aims 12 EMBO actions 2007 15 EMBC actions 2007 17 EMBO & EMBC programmes and activities fellowship programme 20 courses & workshops programme 21 young investigator programme 22 installation grants 23 science & society programme 24 electronic information programme 25 EMBO activities The EMBO Journal 28 EMBO reports 29 Molecular Systems Biology 30 journal subject categories 31 national science reviews 32 women in science 33 gold medal 34 award for communication in the life sciences 35 plenary lectures 36 communications 37 European Life Sciences Forum (ELSF) 38 ➔ 2 table of contents appendix EMBC delegates and advisers 42 EMBC scale of contributions 49 EMBO council members 2007 50 EMBO committee members & auditors 2007 51 EMBO council members 2008 52 EMBO committee members & auditors 2008 53 EMBO members elected in 2007 54 advisory editorial boards & senior editors 2007 64 long-term fellowship awards 2007 66 long-term fellowships: statistics 82 long-term fellowships 2007: geographical distribution 84 short-term fellowship awards 2007 86 short-term fellowships: statistics 104 short-term fellowships 2007: geographical distribution 106 young investigators 2007 108 installation
  • EMBO Facts & Figures

    EMBO Facts & Figures

    excellence in life sciences Reykjavik Helsinki Oslo Stockholm Tallinn EMBO facts & figures & EMBO facts Copenhagen Dublin Amsterdam Berlin Warsaw London Brussels Prague Luxembourg Paris Vienna Bratislava Budapest Bern Ljubljana Zagreb Rome Madrid Ankara Lisbon Athens Jerusalem EMBO facts & figures HIGHLIGHTS CONTACT EMBO & EMBC EMBO Long-Term Fellowships Five Advanced Fellows are selected (page ). Long-Term and Short-Term Fellowships are awarded. The Fellows’ EMBO Young Investigators Meeting is held in Heidelberg in June . EMBO Installation Grants New EMBO Members & EMBO elects new members (page ), selects Young EMBO Women in Science Young Investigators Investigators (page ) and eight Installation Grantees Gerlind Wallon EMBO Scientific Publications (page ). Programme Manager Bernd Pulverer S Maria Leptin Deputy Director Head A EMBO Science Policy Issues report on quotas in academia to assure gender balance. R EMBO Director + + A Conducts workshops on emerging biotechnologies and on H T cognitive genomics. Gives invited talks at US National Academy E IC of Sciences, International Summit on Human Genome Editing, I H 5 D MAN 201 O N Washington, DC.; World Congress on Research Integrity, Rio de A M Janeiro; International Scienti c Advisory Board for the Centre for Eilish Craddock IT 2 015 Mammalian Synthetic Biology, Edinburgh. Personal Assistant to EMBO Fellowships EMBO Scientific Publications EMBO Gold Medal Sarah Teichmann and Ido Amit receive the EMBO Gold the EMBO Director David del Álamo Thomas Lemberger Medal (page ). + Programme Manager Deputy Head EMBO Global Activities India and Singapore sign agreements to become EMBC Associate + + Member States. EMBO Courses & Workshops More than , participants from countries attend 6th scienti c events (page ); participants attend EMBO Laboratory Management Courses (page ); rst online course EMBO Courses & Workshops recorded in collaboration with iBiology.
  • Science & Policy Meeting Jennifer Lippincott-Schwartz Science in The

    Science & Policy Meeting Jennifer Lippincott-Schwartz Science in The

    SUMMER 2014 ISSUE 27 encounters page 9 Science in the desert EMBO | EMBL Anniversary Science & Policy Meeting pageS 2 – 3 ANNIVERSARY TH page 8 Interview Jennifer E M B O 50 Lippincott-Schwartz H ©NI Membership expansion EMBO News New funding for senior postdoctoral In perspective Georgina Ferry’s enlarges its membership into evolution, researchers. EMBO Advanced Fellowships book tells the story of the growth and ecology and neurosciences on the offer an additional two years of financial expansion of EMBO since 1964. occasion of its 50th anniversary. support to former and current EMBO Fellows. PAGES 4 – 6 PAGE 11 PAGES 16 www.embo.org HIGHLIGHTS FROM THE EMBO|EMBL ANNIVERSARY SCIENCE AND POLICY MEETING transmissible cancer: the Tasmanian devil facial Science meets policy and politics tumour disease and the canine transmissible venereal tumour. After a ceremony to unveil the 2014 marks the 50th anniversary of EMBO, the 45th anniversary of the ScienceTree (see box), an oak tree planted in soil European Molecular Biology Conference (EMBC), the organization of obtained from countries throughout the European member states who fund EMBO, and the 40th anniversary of the European Union to symbolize the importance of European integration, representatives from the govern- Molecular Biology Laboratory (EMBL). EMBO, EMBC, and EMBL recently ments of France, Luxembourg, Malta, Spain combined their efforts to put together a joint event at the EMBL Advanced and Switzerland took part in a panel discussion Training Centre in Heidelberg, Germany, on 2 and 3 July 2014. The moderated by Marja Makarow, Vice President for Research of the Academy of Finland.
  • The Cramer Laboratory Unraveled the Structural Basis of Eukaryotic Gene Transcription and Cellular Mechanisms of Gene Regulation

    The Cramer Laboratory Unraveled the Structural Basis of Eukaryotic Gene Transcription and Cellular Mechanisms of Gene Regulation

    The Cramer laboratory unraveled the structural basis of eukaryotic gene transcription and cellular mechanisms of gene regulation. Patrick Cramer determined the first structure of a eukaryotic RNA polymerase, Pol II, with Roger Kornberg (Cramer, Science 2001). Over the last two decades, the Cramer laboratory used a combination of crystallography, cryo-EM, and chemical crosslinking to determine structures of Pol II in many functional complexes (reviewed in Osman, Annu Rev Cell Dev Biol 2020). These include the Pol II pre-initiation complex with the coactivator Mediator, a 46-protein assembly that provides the basis for transcription initiation and regulation. The Cramer lab also developed methods for integrated structural biology of macromolecular assemblies and for functional multi- omics. They established biological concepts such as the tunability of the polymerase active site (Kettenberger, Cell 2003), indirect promoter recognition (Engel, Nature 2013), or elongation-limited initiation regulation of genes (Gressel, eLife 2017). Recently, the Cramer lab reported structures of mammalian Pol II (Bernecky, Nature 2016) and paused and activated complexes (Vos et al., Nature 2018a, 2018b). This elucidated the mechanisms of transcriptional regulation during elongation. Cramer further pioneered structural studies of alternative RNA polymerases. They recently solved the structure of the polymerase of the coronavirus SARS-CoV-2 (Hillen, Nature 2020) and clarified the mechanism of the polymerase inhibitor remdesivir, the only FDA-approved drug for COVID-19 (Kokic, BioRxiv 2020). The Cramer group also resolved first structures of Pol I (Engel, Nature 2013) and the mitochondrial RNA polymerase (Ringel, Nature 2011), and initiation and elongation complexes for both (Engel, Cell 2017; Hillen Cell 2017).